Published on

Medicine – Respiratory Complications of HIV Infection

Respiratory complications are major causes of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection.

They may result from viral, bacterial, mycobacterial or fungal infections. The spectrum of respiratory disease depends on the degree of immunosuppression, CD4+ T-cell count, antiretroviral therapy (ART) status and exposure to infectious organisms.

Major Respiratory Complications
  1. Viral infections: adenovirus, influenza and CMV.
  2. Bacterial infections: Streptococcus pneumoniae and Staphylococcus aureus.
  3. Mycobacterial infections: tuberculosis and Mycobacterium avium complex.
  4. Pneumocystis jirovecii pneumonia (PCP).
  5. Other fungal infections: Candida, Histoplasma and Cryptococcus.

1. Overview of Respiratory Complications

HIV Infection Immune Dysfunction Increased susceptibility to infection Respiratory Complications Viral Adenovirus, influenza, CMV Bacterial Pneumococcus, S. aureus Mycobacterial Tuberculosis, MAC Fungal PCP, Histoplasma, Cryptococcus

Classification of important infectious respiratory complications in HIV.

2. Viral Respiratory Infections

A. Adenovirus

Adenovirus is a non-enveloped, double-stranded DNA virus that can cause upper and lower respiratory tract infections.

Although infection is often self-limiting in immunocompetent individuals, patients with advanced HIV may develop severe or disseminated disease.

Clinical Features

  • Fever.
  • Sore throat.
  • Cough.
  • Nasal congestion.
  • Dyspnoea.
  • Pneumonia in severe cases.

Diagnosis

  • Respiratory tract PCR testing.
  • Chest radiography when pneumonia is suspected.
  • Additional investigations for disseminated infection when indicated.

Treatment

Management is predominantly supportive. Severe adenovirus disease may require specialist-directed antiviral therapy, although evidence for specific treatments is limited.

Examination Point: Adenovirus may cause severe or disseminated respiratory infection in advanced immunosuppression.

B. Influenza

Influenza is caused by influenza A or B viruses. Patients with HIV, particularly those with advanced immunosuppression, may have an increased risk of severe disease.

Clinical Features

  • Sudden-onset fever.
  • Dry cough.
  • Myalgia.
  • Headache.
  • Malaise.
  • Sore throat.
  • Dyspnoea in severe cases.

Complications

  • Primary viral pneumonia.
  • Secondary bacterial pneumonia.
  • Respiratory failure.
  • Exacerbation of underlying respiratory disease.

Secondary bacterial pneumonia may be caused by Streptococcus pneumoniae or Staphylococcus aureus.

Diagnosis and Treatment

  • Respiratory nucleic acid amplification testing.
  • Oseltamivir or another appropriate influenza antiviral.
  • Supportive care.
  • Treatment of secondary bacterial infection when present.
  • Annual influenza vaccination for prevention.
Examination Point: Influenza may cause primary viral pneumonia or predispose to secondary bacterial pneumonia.

C. Cytomegalovirus (CMV)

CMV is a herpesvirus that may reactivate in patients with severe immunosuppression, particularly when the CD4 count falls below approximately 50 cells/µL.

CMV may affect the lungs, retina, gastrointestinal tract and central nervous system.

Clinical Features of CMV Pneumonitis

  • Fever.
  • Dry cough.
  • Progressive dyspnoea.
  • Hypoxaemia.
  • Diffuse pulmonary infiltrates.

True CMV pneumonitis is relatively uncommon in patients with HIV, even when CMV is detected in respiratory specimens.

Diagnosis

  • Compatible clinical and radiological findings.
  • Assessment for alternative causes of pneumonia.
  • Evidence of CMV-associated pulmonary tissue disease.

CMV DNA detected in bronchoalveolar lavage fluid alone does not establish CMV pneumonitis.

Treatment

Confirmed severe CMV pneumonitis may require intravenous ganciclovir or other specialist-directed antiviral treatment.

Examination Point: CMV may cause pneumonitis in advanced HIV, but detection of CMV in respiratory secretions does not necessarily indicate pulmonary disease.

3. Bacterial Respiratory Infections

Bacterial pneumonia can occur at any CD4 count and is an important respiratory complication of HIV infection.

A. Streptococcus pneumoniae

Streptococcus pneumoniae is a Gram-positive, encapsulated, lancet-shaped diplococcus.

It is a major cause of community-acquired bacterial pneumonia.

Clinical Features

  • Acute fever.
  • Productive cough.
  • Purulent sputum.
  • Pleuritic chest pain.
  • Dyspnoea.
  • Tachypnoea.

Chest Radiograph

Classically demonstrates lobar consolidation, although bronchopneumonia and other patterns may occur.

Illustration: Lobar Pneumonia

Consolidation

Schematic illustration of pulmonary consolidation.

View real lobar pneumonia chest radiographs

Complications

  • Bacteraemia.
  • Empyema.
  • Sepsis.
  • Respiratory failure.

Diagnosis and Treatment

  • Chest radiography.
  • Blood cultures in selected severe cases.
  • Sputum culture when indicated.
  • Pneumococcal urinary antigen testing in appropriate cases.
  • Antibiotics according to community-acquired pneumonia guidelines.
  • Pneumococcal vaccination for prevention.
Examination Point: Streptococcus pneumoniae is a major cause of bacterial pneumonia in HIV and may cause invasive pneumococcal disease.

B. Staphylococcus aureus

Staphylococcus aureus is a Gram-positive coccus arranged in clusters.

It may cause severe pneumonia, particularly following influenza or in patients with additional risk factors.

Clinical Features

  • High fever.
  • Productive cough.
  • Dyspnoea.
  • Pleuritic chest pain.
  • Haemoptysis in some cases.

Complications

  • Necrotising pneumonia.
  • Lung abscesses.
  • Cavitary pulmonary lesions.
  • Empyema.
  • Bacteraemia and sepsis.

Methicillin-resistant Staphylococcus aureus (MRSA) should be considered when relevant risk factors are present.

Diagnosis and Treatment

  • Chest radiography or CT.
  • Sputum culture.
  • Blood cultures in severe disease.
  • Antibiotic treatment guided by susceptibility.
  • Vancomycin or linezolid may be required for MRSA pneumonia.
Examination Point: Staphylococcus aureus may cause severe necrotising or cavitating pneumonia, particularly after influenza.

4. Tuberculosis in HIV Infection

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a major respiratory and systemic complication of HIV infection.

TB can occur at any CD4 count.

Unlike some opportunistic infections, tuberculosis does not require profound CD4 depletion. However, its clinical and radiological presentations vary with immune status.

Clinical Features

  • Persistent cough.
  • Fever.
  • Night sweats.
  • Weight loss.
  • Fatigue.
  • Haemoptysis in some cases.

Important Characteristics of TB in HIV

A. Common Respiratory Presentation

Pulmonary tuberculosis is a major cause of chronic respiratory symptoms in people living with HIV.

B. Extrapulmonary Disease Is Common

HIV increases the likelihood of disseminated and extrapulmonary tuberculosis.

  • Lymph nodes.
  • Meninges.
  • Pleura.
  • Pericardium.
  • Abdomen.
  • Bones and joints.

C. Chest Radiographs May Be Atypical

Classical pulmonary tuberculosis in immunocompetent adults often produces upper-lobe infiltrates and cavitation.

In advanced HIV, chest imaging may instead show:

  • Lower or middle-zone infiltrates.
  • Hilar or mediastinal lymphadenopathy.
  • Diffuse or miliary infiltrates.
  • Minimal cavitation.
  • Occasionally a normal chest radiograph.

Illustration: TB Radiological Patterns

Relatively Preserved Immunity Advanced HIV Upper-lobe cavitation Atypical or diffuse disease

Schematic comparison. Actual imaging patterns overlap and cannot independently establish the diagnosis.

View real HIV-associated tuberculosis chest radiographs

D. Drug Resistance

Drug-resistant TB, including multidrug-resistant tuberculosis (MDR-TB), is an important concern in people living with HIV.

However, HIV infection does not automatically imply drug resistance. Risk depends on prior treatment, exposure, local epidemiology and other factors.

MDR-TB is defined by resistance to at least isoniazid and rifampicin.

E. Nontuberculous Mycobacterial Infections

Advanced HIV may predispose patients to infections caused by nontuberculous mycobacteria, particularly Mycobacterium avium complex (MAC).

F. TB Can Occur at Any CD4 Count

This is a key distinction between tuberculosis and several other HIV-associated opportunistic infections.

Diagnosis of Tuberculosis

  • Sputum molecular testing such as Xpert MTB/RIF or Xpert Ultra.
  • Sputum smear microscopy.
  • Mycobacterial culture.
  • Drug-susceptibility testing.
  • Chest radiography.
  • Site-specific testing for extrapulmonary disease.

Treatment

Drug-susceptible TB is generally treated with an initial multidrug regimen containing:

  • Isoniazid.
  • Rifampicin.
  • Pyrazinamide.
  • Ethambutol.

Treatment duration and continuation regimens depend on disease site, susceptibility and clinical response.

ART is essential, but timing and interactions between antiretroviral and antituberculous drugs require careful management.

Examination Point: TB can occur at any CD4 count. Advanced HIV is associated with more extrapulmonary or disseminated disease and may produce atypical chest radiographs with less cavitation.

5. Mycobacterium avium Complex (MAC)

Mycobacterium avium complex consists of nontuberculous mycobacteria capable of causing opportunistic disease in patients with advanced HIV.

Disseminated MAC most commonly occurs when the CD4 count is below approximately 50 cells/µL.

Clinical Features

  • Persistent fever.
  • Night sweats.
  • Weight loss.
  • Fatigue.
  • Diarrhoea.
  • Abdominal pain.
  • Lymphadenopathy.
  • Anaemia.

Although pulmonary MAC disease can occur, disseminated infection is the classical presentation in advanced HIV.

Diagnosis

  • Mycobacterial blood cultures in suspected disseminated disease.
  • Culture or molecular testing from involved tissues.
  • Imaging and site-specific investigations when indicated.

Treatment

Treatment generally includes a macrolide such as azithromycin or clarithromycin combined with ethambutol.

Additional drugs may be required in selected cases. Effective ART is essential for immune recovery.

Examination Point: Disseminated MAC is classically associated with CD4 counts below 50 cells/µL and causes fever, weight loss, diarrhoea and systemic illness.

6. Pneumocystis Pneumonia (PCP)

Pneumocystis pneumonia (PCP), also called Pneumocystis jirovecii pneumonia (PJP), is caused by the fungus Pneumocystis jirovecii.

It is a major AIDS-defining opportunistic infection.

PCP most commonly occurs when the CD4 count is below 200 cells/µL, particularly in patients not receiving effective ART or appropriate prophylaxis.

Pathogenesis

Pneumocystis jirovecii infects the alveoli, causing inflammation and impaired gas exchange.

Advanced HIV Infection CD4 Commonly Below 200 Pneumocystis Infection of the Alveoli Impaired Gas Exchange Hypoxaemia and Progressive Dyspnoea

Clinical Features

PCP typically has a subacute presentation developing over days to weeks.

  • Progressive dyspnoea.
  • Dry, nonproductive cough.
  • Fever.
  • Malaise.
  • Fatigue.
  • Tachypnoea.
  • Hypoxaemia.

Patients may have relatively few chest auscultation findings despite significant hypoxaemia.

Chest Radiograph

Chest radiography is abnormal in most established cases, with traditional teaching estimates of approximately 90%.

  • Bilateral diffuse interstitial infiltrates.
  • Symmetrical perihilar opacities.
  • Ground-glass changes, more clearly seen on CT.

An early chest radiograph may be normal and therefore does not completely exclude PCP.

Illustration: Diffuse Pulmonary Infiltrates

Schematic illustration of bilateral diffuse pulmonary infiltrates.

View real PCP chest radiographs

Diagnosis

  • Pulse oximetry.
  • Arterial blood gas in moderate or severe disease.
  • Chest radiography or CT.
  • Induced sputum or bronchoalveolar lavage.
  • Pneumocystis PCR or staining.
  • Serum beta-D-glucan as a supportive, nonspecific test.

Treatment

First-line treatment is high-dose co-trimoxazole (trimethoprim-sulfamethoxazole, TMP-SMX), generally for 21 days in patients with HIV.

Adjunctive Corticosteroids

Adjunctive corticosteroids are recommended for moderate-to-severe PCP, commonly defined by:

  • Arterial PaO2 below 70 mmHg on room air, or
  • Alveolar–arterial oxygen gradient of at least 35 mmHg.

When indicated, corticosteroids should be started early, ideally within 72 hours of beginning anti-PCP treatment.

Prophylaxis

TMP-SMX is also used for primary and secondary prophylaxis in patients meeting guideline-defined criteria, commonly involving low CD4 counts and inadequate viral suppression.

Examination Point: PCP classically causes subacute fever, dry cough, progressive dyspnoea, hypoxaemia and bilateral diffuse pulmonary infiltrates in patients with CD4 counts below 200 cells/µL.

7. Other Fungal Respiratory Infections

A. Candida Species

Candida species frequently colonise the oropharynx and may be detected in respiratory specimens.

However, true Candida pneumonia is extremely rare, including in patients with HIV.

Candida isolated from sputum or bronchoalveolar lavage usually represents colonisation rather than invasive pulmonary infection.

Clinical Features of True Invasive Disease

  • Fever.
  • Cough.
  • Dyspnoea.
  • Pulmonary infiltrates.

Diagnosis and Treatment

  • Histopathological evidence of tissue invasion is generally required.
  • Systemic antifungal treatment is guided by species and susceptibility.
  • Assessment for disseminated candidiasis is important.
Examination Point: Candida isolated from sputum usually represents colonisation, not Candida pneumonia.

B. Histoplasmosis

Histoplasmosis is caused by Histoplasma capsulatum, a dimorphic fungus.

Infection is generally acquired through inhalation of environmental fungal spores.

Patients with advanced HIV are at risk of disseminated histoplasmosis, especially in endemic regions.

Clinical Features

  • Fever.
  • Cough.
  • Dyspnoea.
  • Weight loss.
  • Night sweats.
  • Hepatosplenomegaly in disseminated disease.
  • Lymphadenopathy.
  • Pancytopenia in severe disseminated infection.

Diagnosis

  • Histoplasma antigen testing in urine or serum.
  • Fungal culture.
  • Histopathological examination.
  • Molecular testing where available.

Treatment

  • Severe disseminated disease: liposomal amphotericin B followed by itraconazole.
  • Milder disease: itraconazole in appropriate cases.
  • ART and management of associated immunosuppression.
Examination Point: Histoplasmosis may cause pulmonary or disseminated infection in advanced HIV and can resemble tuberculosis.

C. Cryptococcus neoformans

Cryptococcus neoformans is an encapsulated yeast.

Infection is usually acquired through inhalation, with possible dissemination to the central nervous system.

Clinical Features

  • Cough.
  • Fever.
  • Dyspnoea.
  • Chest discomfort.
  • Pulmonary nodules or infiltrates.
  • Disseminated disease in advanced immunosuppression.

Diagnosis

  • Serum cryptococcal antigen testing.
  • Respiratory or tissue fungal culture.
  • Histopathology.
  • Evaluation for CNS involvement when indicated.

Treatment

  • Mild isolated pulmonary disease: fluconazole in appropriate cases.
  • Severe pulmonary or disseminated disease: amphotericin B-based treatment, with flucytosine when appropriate.
  • ART and immune restoration, with timing adapted to any CNS involvement.
Examination Point: Cryptococcus is an encapsulated yeast that can cause pulmonary infection and disseminate to the CNS, producing cryptococcal meningitis.

8. Comparison of Respiratory Complications

Condition Typical Presentation Important Clue
AdenovirusFever, cough, respiratory infectionMay be severe in advanced immunosuppression
InfluenzaAcute fever, myalgia, coughSecondary bacterial pneumonia
CMV pneumonitisFever, dry cough, hypoxaemiaAdvanced HIV; tissue disease must be established
Pneumococcal pneumoniaAcute fever, productive coughLobar consolidation
S. aureus pneumoniaSevere pneumonia, sometimes haemoptysisNecrosis or cavitation
TuberculosisChronic cough, fever, weight lossCan occur at any CD4 count
Disseminated MACFever, weight loss, diarrhoeaCD4 commonly below 50
PCPDry cough, progressive dyspnoeaCD4 commonly below 200; hypoxaemia
Candida pneumoniaRare invasive pulmonary infectionRespiratory Candida usually represents colonisation
HistoplasmosisPulmonary or disseminated diseaseMay mimic TB
CryptococcosisPulmonary nodules or infiltratesMay disseminate to CNS

9. Typical CD4 Count Associations

These are approximate clinical associations, not strict diagnostic thresholds.

Typical CD4 Associations Any CD4 Count Bacterial pneumonia, influenza, TB CD4 Below Approximately 200 Pneumocystis pneumonia CD4 Below Approximately 100 Severe disseminated fungal infections CD4 Below Approximately 50 Disseminated MAC and CMV disease

10. High-Yield Examination Summary

Viral Infections

  • Adenovirus: may cause severe respiratory disease.
  • Influenza: acute infection with risk of secondary bacterial pneumonia.
  • CMV: pneumonitis is uncommon but may occur in advanced HIV.

Bacterial Infections

  • Streptococcus pneumoniae: major cause of bacterial pneumonia.
  • Staphylococcus aureus: may cause necrotising or cavitating pneumonia.

Tuberculosis

  • Can occur at any CD4 count.
  • Extrapulmonary and disseminated disease are more common in advanced HIV.
  • Chest radiographs may be atypical.
  • Drug-resistant TB is an important concern.

Pneumocystis Pneumonia

  • Usually occurs with CD4 below 200 cells/µL.
  • Dry cough, fever, malaise and progressive dyspnoea.
  • Hypoxaemia and diffuse bilateral infiltrates.
  • High-dose co-trimoxazole is first-line treatment.
  • Adjunctive corticosteroids for moderate-to-severe disease.

Other Fungal Infections

  • Candida: respiratory isolation usually represents colonisation.
  • Histoplasmosis: pulmonary or disseminated fungal infection.
  • Cryptococcus: pulmonary infection with possible CNS dissemination.
Most Important Examination Distinction

Tuberculosis can occur at any CD4 count, whereas PCP is particularly associated with CD4 counts below 200 cells/µL. TB may have an atypical chest radiograph in advanced HIV, while PCP classically produces diffuse bilateral pulmonary infiltrates and significant hypoxaemia.

Clinical Warning

New or worsening breathlessness, low oxygen saturation, chest pain or respiratory distress requires urgent medical assessment.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments